Korean Study on Safety and Effectiveness of OAD Triple Therapy in Type 2 Diabetes

Clinical trial NCT06838286 · RECRUITING

Trial details

NCT number: NCT06838286
Sponsor: Chong Kun Dang Pharmaceutical
Status: RECRUITING
Study type: OBSERVATIONAL

Diabetes Mellitus, Type 2

Start date: 2024-03-16
Primary completion: 2026-12-31
Enrollment: 10000

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.